UnitedHealth Group Shares Rise 6.7% After Announcing $1.5 Billion AI Cost-Cutting Push

UnitedHealth Group shares jumped 6.7% in late June, hitting a 52-week high near $427, after the company unveiled a $1.5 billion AI investment targeting $1 billion in direct cost savings by year-end. The rally marks a sharp comeback for a stock that bottomed near $234 in April 2025 following an earnings miss and CEO resignation, according to Yahoo Finance.
The surge is also powered by UNH's 17th consecutive annual dividend increase — a 5% raise to $2.32 per share quarterly — cementing its status as a blue-chip income stock. The bull case has fundamentally shifted: this is no longer just a bet on an aging population, but on whether a healthcare giant can become an AI-first cost-cutting machine.
The centrepiece of UNH's recovery is its "Optum Insight" AI platform, which CEO Stephen Hemsley calls "a reimagining of how we organize, operate and work," according to Endpoints News. The company now runs 117 large language models, employs 20,000 AI engineers, and has built over 1,000 internal AI use cases. One example: AI-powered prescription approvals now take 30 seconds, down from 8 hours.
Optum Insight CEO Sandeep Dadlani says one-third of the $1.5 billion goes to software products, while two-thirds targets core business processes. Tim Noel, who runs the insurance arm UnitedHealthcare, added that over 80% of member calls now use AI tools — freeing human staff for more complex work. Analysts at BofA Securities kept a "Buy" rating with a $475 price target, citing margin recovery as the key driver, according to Ticker Nerd.
UNH made a deliberate choice to shrink. The company plans to shed 1.3 million to 1.4 million Medicare Advantage members in 2026, walking away from underperforming markets to protect profits. Its Medicare Advantage market share dropped from 29% to 26% as a result, according to KFF.
The strategy is already showing results. The Medical Care Ratio — the share of premiums paid out as medical costs — dropped to 83.9% in Q1 2026, well below the 85.5% analysts feared, according to Motley Fool. UNH posted adjusted earnings of $7.23 per share on $111.7 billion in revenue, beating estimates. The company is up 25% year-to-date overall.
UNH's pivot did not happen by choice alone. In 2024, the Change Healthcare cyberattack cost the company billions in lost productivity and remediation. Then in 2025, the DOJ launched criminal and civil investigations into UNH's billing practices and its ties between Optum and UnitedHealthcare, according to Motley Fool. CEO Andrew Witty resigned in April 2025 after a major earnings miss and the suspension of all forward guidance.
On top of that, the Centers for Medicare & Medicaid Services gave UNH just a 0.09% rate increase for 2026 — a figure company leaders said did not reflect real medical cost trends, according to Becker's Healthcare. Medical cost inflation is running at roughly 10% annually, squeezing margins on every Medicare Advantage plan UNH sells.
Not everyone is convinced. Analysts at Seeking Alpha point to a "trust gap" with investors still rattled by the 2025 chaos. A Gallup poll cited by TipRanks found that 69% of the public does not trust businesses to use AI responsibly in healthcare. Critics argue that the AI push is designed to automate claim denials, not improve patient care — a claim at the centre of several ongoing lawsuits.
The biggest financial risk remains Medicare Advantage utilization. If sick members use more care than expected, the $1 billion in savings could evaporate quickly. Regulators are also watching closely: as AI agents begin calling doctors' offices to schedule appointments — a pilot already underway — the DOJ and CMS are expected to issue new rules on "algorithmic care denials," according to Bloomberg.
Publishers
4
Articles
4
Reach
4